drugset / Trial / NCT03070353
Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury
NaSingle-groupOpen-labelTreatment
Summary
A pilot study of Dextran-40 infusion in patients with decompensated cirrhosis presenting with AKI
Timeline
- Start
- 2015-07-01
- Primary completion
- 2016-06-30
- Completion
- 2016-06-30
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextran 40 | Unknown | 10 ml | — |
| Subject | Dextran 40 | Unknown | 1 g/kg | — |